Dimensional Fund Advisors LP Akebia Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.3 - $0.46 $46,537 - $71,357	-155,126 Reduced 19.82%	627,549 $199,000
Q2 2022 Aug 12, 2022	SELL	$0.32 - $0.67 $602,939 - $1.26 Million	-1,884,186 Reduced 70.65%	782,675 $276,000
Q1 2022 May 13, 2022	BUY	$0.72 - $2.93 $52,574 - $213,948	73,020 Added 2.82%	2,666,861 $1.92 Million
Q4 2021 Feb 09, 2022	BUY	$2.26 - $3.34 $1.13 Million - $1.66 Million	498,078 Added 23.77%	2,593,841 $5.86 Million
Q3 2021 Nov 12, 2021	SELL	$2.35 - $3.88 $3.08 Million - $5.08 Million	-1,309,358 Reduced 38.45%	2,095,763 $6.04 Million
Q2 2021 Aug 12, 2021	BUY	$2.83 - $4.2 $2.75 Million - $4.09 Million	972,862 Added 40.0%	3,405,121 $12.9 Million
Q1 2021 May 14, 2021	BUY	$2.92 - $5.06 $2 Million - $3.47 Million	684,955 Added 39.2%	2,432,259 $8.23 Million
Q4 2020 Feb 25, 2021	BUY	$2.22 - $3.78 $3.88 Million - $6.6 Million	1,747,304 New	1,747,304 $4.89 Million

120

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $324M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.